News
Quality of life decrement with salvage ASCT is short-lived
Salvage stem cell transplant in patients with multiple myeloma was linked to short-term, but not long-term, declines in quality of life, compared...
News
RIT consolidation may be an option for unfit MCL patients
Patients who could not undergo transplants had high rates of complete responses to radioimmunotherapy consolidation following induction...
News
Adding MET TKI may overcome NSCLC resistance
ATLANTA – Combining the investigational MET inhibitor savolitinib to osimertinib was associated with responses in NSCLC resistant to EGFR-targeted...
Video
Gilteritinib prolonged survival in FLT3-mutated AML
Patients with acute myeloid leukemia and FLT3-activating mutations are at increased risk for early relapse and poor overall survival.
News
MET/MEK inhibitor duo shows activity in resistant NSCLC
ATLANTA – About one-third of patients with heavily pretreated non–small cell lung cancer had responses to osimertinib and selumetinib.
News
CAR T cells home in on HER2 in advanced sarcomas
ATLANTA – A teenage girl with advanced osteosarcoma has had a durable complete remission after receiving CAR T cells targeted to HER2.
Video
Novel chemo/PARP inhibitor strategy promising for advanced pancreatic cancer
ATLANTA – Investigators are treating patients with advanced pancreatic cancer and homologous recombination deficiencies with a novel strategy of...
Video
Genetic variant increases stroke risk in childhood cancer survivors
ATLANTA - Dr. Yadav Sapkota of St. Jude Children's Research Hospital discusses the identification of a genetic variant that is strongly associated...
Video
Anti-EGFR TKI, MET inhibitor team up against drug-resistant NSCLC
ATLANTA – Dr. Lecia Sequist discusses early results from the TATTON trial, which is evaluating osimertinib plus...
Video
CAR T cells target HER2 expression in advanced sarcomas
ATLANTA – Although HER2 expression in osteosarcoma and rhabomyosarcoma is too low for HER2-targeted therapies such...
News
Anastrozole/fulvestrant prolongs OS in metastatic ER+ breast cancer
Women with no prior tamoxifen exposure benefited most from the combination, compared with those receiving anastrozole alone.
News
Plasma genotyping yields actionable mutation in advanced NSCLC
Noninvasive ultra-deep sequencing of cell-free plasma DNA identified driver mutations with results comparable to those of genotyping of biopsied...
News
HDACi, HMA combo improves survival for older AML patients
Patients older than 65 years who were ineligible for induction chemotherapy benefited from the addition of pracinostat to the standard of care...
News
Novel immunostimulant combo shows early efficacy
SAN FRANCISCO – A one-two approach to stimulating both innate and adaptive immunity appears to be paying off, suggest early efficacy data from a...
News
Antibiotics gut checkpoint inhibitor efficacy
SAN FRANCISCO – Patients who had received antibiotics more than a month before a checkpoint inhibitor had significantly worse survival, regardless...